XCUR Competitors & Alternatives
Compare Exicure Inc with similar stocks in the same industry
Biotechnology
XCUR
Main Stock$1.10
Tradestie Score
39
Market Cap
$25.90M
Revenue Growth
9.3%
Analyst Upside
+81.8%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$31.75
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.87
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.54
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.21
|
$84.52M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.17
|
$67.94M | - | 46 | Compare |
|
PHIO
Phio Pharmaceuticals Corp. Common Stock
|
$0.81
|
$13.86M | - | 53 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.39
|
$7.21M | - | 68 | Compare |
|
QNRX
Quoin Pharmaceuticals, Ltd. American Depositary Shares
|
$3.75
|
$4.25M | - | 48 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$0.67
|
$3.50M | - | 41 | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More XCUR Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry